Stock Taper
MCK
MCKESSON CORPORATION
NYSE
$924.78
▲ UP 1.99% (18.01)

KEY STATISTICS

Market Cap$108.24 B
52w High$999.00
52w Low$682.35
Dividend Yield0.41%
FrequencyQuarterly
P/E22.66
Volume821.54K
Shares Out.117.08M

COMPANY

LEADERSHIP

Brian S. Tyler
CHIEF EXECUTIVE
Brian S. Tyler

COMPENSATION 2026

Salary$1,591,667
Stock Awards$17,201,202
Incentive Plan Pay$4,456,668
All Other Comp.$963,507
Total$24,213,044

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 10, 1994
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
42,300

PRICE TARGET

Target High$1085.00
Target Low$845.00
Target Median$985.00
Target Consensus$971.63

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$109.91B
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
1998-01-05Forward2:1

PRICE

$924.78 ▲ UP 1.99% (+$18.01)
OVERLAYS
$916$920$9249:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM924.78

About McKesson Corporation

https://www.mckesson.com ↗

McKesson Corporation, founded in 1833 and headquartered in Texas, provides healthcare services globally through segments including pharmaceutical distribution, medical-surgical supplies, international distribution, and prescription technology solu...

INDUSTRY

Medical - Distribution

A PRODUCT MCKESSON CORPORATION IS KNOWN FOR

Foster & Thrive
Foster & Thrive

Foster & Thrive, McKesson's private label of over 270 OTC health and wellness products, consolidates Health Mart and Sunmark lines, highlighting the company's focus on the consumer health market.

Revenue by Products

IconPRODUCTQ2-2026Q3-2026Q4-2026Q1-2027
North American Pharmaceutical Segment$86.48B $88.32B $161.85B $86.77B
Oncology And Multispecialty Segment$12.04B $13.01B $23.37B $14.22B
MedicalSurgical Solutions Segment$2.95B $2.99B $2.87B $2.82B
Prescription Technology Solutions Segment$1.38B $1.5B $2.93B $1.57B
Segment Reporting Reconciling Item Excluding Corporate Nonsegment$302M $335M $406M

Revenue by Geography

MapREGIONQ2-2020Q3-2020Q4-2020Q1-2021
UNITED STATES$48.29B $49.31B $48.79B $47.13B
International Segment$9.32B $9.86B $9.75B $8.55B

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book1
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Elizabeth Fletcher
Elizabeth Fletcher
Sale
2026-04-08
Lizzie Fletcher
Lizzie Fletcher
Sale
2026-04-08
SENATE TRADES
Markwayne Mullin
Markwayne Mullin
Purchase
2026-02-04
HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Sale (Full)
2025-12-19

INSIDER TRADES

OFFICER: EVP AND CHIEF STRATEGY OFFICER
Srinivasan Ramesh (NMN)
Purchase · 368 shares
2026-08-07
DIRECTOR
Lerman Bradley E
Sale · 301 shares
2026-08-10
OFFICER: EVP AND CHIEF STRATEGY OFFICER
Srinivasan Ramesh (NMN)
· —
2026-08-01
OFFICER: EVP AND CHIEF STRATEGY OFFICER
Srinivasan Ramesh (NMN)
· 316 shares
2026-08-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OVERWEIGHT 3
OUTPERFORM 3
EQUAL WEIGHT 1
NEUTRAL 1
14 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
VRTX$553.57COMPARE
BMY$67.33COMPARE
CVS$98.00COMPARE
SYK$313.68COMPARE
MDT$93.20COMPARE
SNY$44.62COMPARE
GSK$50.41COMPARE
HCA$407.35COMPARE